Tetrahydroxy stilbene glucoside alters neurogenesis and neuroinflammation to ameliorate radiation-associated cognitive disability via AMPK/Tet2

• Published in: International immunopharmacology Vol. 110; p. 108928
• Main Authors: Miao, Bei-bei, Gao, Dan, Hao, Jin-ping, Li, Ya-li, Li, Lin, Wang, Jia-bo, Xiao, Xiao-he, Yang, Cui-cui, Zhang, Lan
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01.09.2022
• Subjects: AMPK/Tet2; Cognitive disability; Neurogenesis; Neuroinflammation; Radiation; Tetrahydroxy stilbene glucoside; Tetrahydroxy stilbene glucoside; AMPK/Tet2; Neuroinflammation; Cognitive disability; Neurogenesis; Radiation
• ISSN: 1567-5769; 1878-1705
• DOI: 10.1016/j.intimp.2022.108928

•Identifying a natural AMPK activator TSG to treat radiation-induced cognitive disability.•TSG promotes neurogenesis via AMPK/Tet2.•TSG inhibits neuroinflammation via AMPK. Along with the extensive application of radiation in medical, military and other fields, human beings carry a greater risk of exposure to radiation environment that causes a range of physical injure, particularly to the brain in cognition. However, the radiation-associated cognitive disability is poorly understood and there is no effective prevention or long-term treatment. Here, we demonstrate that neurogenesis and neuroinflammation disorder are primarily involved in the pathophysiological basis of irradiation-induced cognitive decline. Furthermore, we discovered that tetrahydroxy stilbene glucoside (TSG), a natural active ingredient from Heshouwu that has been well known for its unique anti-aging effect as the Chinese herb, can be a promising mitigator to improve learning-memory ability by facilitating the neurogenesis in the proliferation and differentiation of the surviving neural progenitor cells via AMPK/Tet2, and attenuating the neuroinflammation in the microglial NLRP3 inflammasomes activation via AMPK in vivo. Additionally, TSG was also revealed to activate AMPK by molecular docking and kinase enzyme system assay in vitro. Taken together, our findings identify TSG, as the AMPK activator, prevents radiation-induced cognitive dysfunction by regulating neurogenesis and neuroinflammation via AMPK/Tet2 in rodents, and represents a very promising candidate for developing drugs that can be used for radiation-associated brain injury.